AUTHOR=Zhang Lin , Lin Yexiang , Wang Kaiyue , Han Lifeng , Zhang Xue , Gao Xiumei , Li Zheng , Zhang Houliang , Zhou Jiashun , Yu Heshui , Fu Xuebin 

TITLE=Multiple-model machine learning identifies potential functional genes in dilated cardiomyopathy

JOURNAL=Frontiers in Cardiovascular Medicine

VOLUME=9

YEAR=2023

URL=https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2022.1044443

DOI=10.3389/fcvm.2022.1044443

ISSN=2297-055X

ABSTRACT=<sec><title>Introduction</title><p>Machine learning (ML) has gained intensive popularity in various fields, such as disease diagnosis in healthcare. However, it has limitation for single algorithm to explore the diagnosing value of dilated cardiomyopathy (DCM). We aim to develop a novel overall normalized sum weight of multiple-model MLs to assess the diagnosing value in DCM.</p></sec><sec><title>Methods</title><p>Gene expression data were selected from previously published databases (six sets of eligible microarrays, 386 samples) with eligible criteria. Two sets of microarrays were used as training; the others were studied in the testing sets (ratio 5:1). Totally, we identified 20 differently expressed genes (DEGs) between DCM and control individuals (7 upregulated and 13 down-regulated).</p></sec><sec><title>Results</title><p>We developed six classification ML methods to identify potential candidate genes based on their overall weights. Three genes, serine proteinase inhibitor A3 (<italic>SERPINA3</italic>), frizzled-related proteins (FRPs) 3 (<italic>FRZB</italic>), and ficolin 3 (<italic>FCN3</italic>) were finally identified as the receiver operating characteristic (ROC). Interestingly, we found all three genes correlated considerably with plasma cells. Importantly, not only in training sets but also testing sets, the areas under the curve (AUCs) for <italic>SERPINA3</italic>, <italic>FRZB</italic>, and <italic>FCN3</italic> were greater than 0.88. The ROC of <italic>SERPINA3</italic> was significantly high (0.940 in training and 0.918 in testing sets), indicating it is a potentially functional gene in DCM. Especially, the plasma levels in DCM patients of SERPINA3, FCN, and FRZB were significant compared with healthy control.</p></sec><sec><title>Discussion</title><p>SERPINA3, FRZB, and FCN3 might be potential diagnosis targets for DCM, Further verification work could be implemented.</p></sec>